Table of Contents Table of Contents
Previous Page  418 / 1851 Next Page
Information
Show Menu
Previous Page 418 / 1851 Next Page
Page Background

ADCC: enhancement of antibody-based tumor therapy ↔ small molecular agents

Antibody-Dependent Cellular Cytotoxicity Mediated

by mABs , e.g. Cetuximab